Display options
Cite
Walden RJ, Prichard BN. Post-marketing drug surveillance. Br J Clin Pharmacol. 1978;6(3):191-2doi: 10.1111/j.1365-2125.1978.tb04584.x.
Walden, R. J., & Prichard, B. N. (1978). Post-marketing drug surveillance. British journal of clinical pharmacology, 6(3), 191-2. https://doi.org/10.1111/j.1365-2125.1978.tb04584.x
Walden, R J, and Prichard, B N. "Post-marketing drug surveillance." British journal of clinical pharmacology vol. 6,3 (1978): 191-2. doi: https://doi.org/10.1111/j.1365-2125.1978.tb04584.x
Walden RJ, Prichard BN. Post-marketing drug surveillance. Br J Clin Pharmacol. 1978 Sep;6(3):191-2. doi: 10.1111/j.1365-2125.1978.tb04584.x. PMID: 687497; PMCID: PMC1429459.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley Free PMC Article

Br J Clin Pharmacol. 1978 Sep;6(3):191-2. doi: 10.1111/j.1365-2125.1978.tb04584.x.

Post-marketing drug surveillance.

British journal of clinical pharmacology

R J Walden, B N Prichard

PMID: 687497 PMCID: PMC1429459 DOI: 10.1111/j.1365-2125.1978.tb04584.x
Free PMC Article

[No abstract available.]

Similar articles

References

  1. Br Med J. 1977 Oct 15;2(6093):1001-3 - PubMed
  2. Br Med J. 1977 Mar 12;1(6062):691-2 - PubMed
  3. Br Med J. 1977 Jan 8;1(6053):96-7 - PubMed

MeSH terms

Publication Types

LinkOut - more resources